Dr. Furman on The Diminishing Role of FCR in CLL (chronic lymphocytic leukemia)
As we're getting ready to head to ASH this week, we wanted to post in response to a query that was posted originally on the CLLSLL io group forum. Dr. Richard Furman is their medical advisor and his response really puts the comparison of a therapy that has existed for decades with a therapy that is less than a decade old. You can read my commentary and the text from Dr. Furman's post https://cllsociety.org/2017/12/one-mans-opinion-fcr-vs-ibrutinib/.
We'll be going night and day at ASH and plan to post while we are there. Stay tuned.
posted by Brian Koffman at
8:29 PM
1 Comments:
Great information,I am very happy to your post about on. Great information,I would like to say your post is very informative.you did a wonderful thing and should be proud of yourself for sharing.Thank you! I am very happy to your post its a great post.
clinical evidence.com
Post a Comment
Subscribe to Post Comments [Atom]
<< Home